PV Bulletin

Recall: Nature's Own Glucosamine Sulfate with Chondroitin and Magnesium Glycinate 1150mg

Potential presence of glass fragments in specific batches poses risk of injury.

Primary source: https://www.tga.gov.au/news/safety-recalls/natures-own-glucosamine-sulfate-chondroitin-and-magnesium-glycinate

PV Impact Brief

Urgency: HighConfidence: high

What changed

TGA issued a recall for Nature's Own Glucosamine Sulfate with Chondroitin (320 pack) batch 1662937 and Nature's Own Magnesium Glycinate 1150mg (300 pack) batch 1665576 due to potential glass fragments.

Why it matters

Consumption of affected product may cause injury from glass fragments.

Action needed

Stop using affected batches; return to place of purchase for full refund.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Regulatory action details

Action type
Recall
Publication date
2026-06-04
Safety issue
Potential presence of glass fragments in specific batches of these supplement products, posing a risk of injury if consumed.

Affected products

  • Nature's Own Glucosamine Sulfate with Chondroitin (320 pack)
    Sanofi-Aventis Healthcare
    1662937
  • Nature's Own Magnesium Glycinate 1150mg (300 pack)
    Sanofi-Aventis Healthcare
    1665576

PV internal implications

Stop using the products from the affected batches. Return the product to the place of purchase for a full refund.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 4, 2026

Full briefing

Practical implication

Stop using affected batches; return to place of purchase for full refund.

TGA recalls two Sanofi-Aventis supplements due to glass fragments in batches 1662937 and 1665576.

What changed: TGA issued a recall for Nature's Own Glucosamine Sulfate with Chondroitin (320 pack) batch 1662937 and Nature's Own Magnesium Glycinate 1150mg (300 pack) batch 1665576 due to potential glass fragments.

Why it matters: Consumption of affected product may cause injury from glass fragments.

Practical implication: Stop using affected batches; return to place of purchase for full refund.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Recall#Safety Signal#Safety Signals#firecrawl-agent#regulatory-extraction#Therapeutic Goods Administration (TGA)

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward